Contrasting Decision Diagnostics (OTCMKTS:DECN) & Rigetti Computing (NASDAQ:RGTI)

Decision Diagnostics (OTCMKTS:DECNGet Free Report) and Rigetti Computing (NASDAQ:RGTIGet Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Valuation and Earnings

This table compares Decision Diagnostics and Rigetti Computing”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Decision Diagnostics N/A N/A N/A N/A N/A
Rigetti Computing $11.89 million 144.40 -$75.11 million ($0.38) -23.50

Decision Diagnostics has higher earnings, but lower revenue than Rigetti Computing.

Analyst Ratings

This is a summary of current ratings and recommmendations for Decision Diagnostics and Rigetti Computing, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Decision Diagnostics 0 0 0 0 0.00
Rigetti Computing 0 0 5 0 3.00

Rigetti Computing has a consensus price target of $4.80, suggesting a potential downside of 46.25%. Given Decision Diagnostics’ higher probable upside, equities analysts clearly believe Decision Diagnostics is more favorable than Rigetti Computing.

Profitability

This table compares Decision Diagnostics and Rigetti Computing’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Decision Diagnostics N/A N/A N/A
Rigetti Computing -509.58% -51.56% -37.78%

Volatility and Risk

Decision Diagnostics has a beta of -1.53, indicating that its share price is 253% less volatile than the S&P 500. Comparatively, Rigetti Computing has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500.

Institutional and Insider Ownership

35.4% of Rigetti Computing shares are owned by institutional investors. 2.8% of Rigetti Computing shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Rigetti Computing beats Decision Diagnostics on 6 of the 10 factors compared between the two stocks.

About Decision Diagnostics

(Get Free Report)

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.

About Rigetti Computing

(Get Free Report)

Rigetti Computing, Inc., through its subsidiaries, builds quantum computers and the superconducting quantum processors. The company offers cloud in a form of quantum processing unit, such as 9-qubit chip and Ankaa-2 system under the Novera brand name; and sells access to its quantum computers through quantum computing as a service. It also provides quantum cloud services that provides various range of support in programming, public or private clouds integration, and connectivity, as well as quantum operating system software that supports both public and private cloud architectures. In addition, the company offers professional services, such as algorithm development, benchmarking, quantum application programming, and software development. The company serves commercial enterprises, government organizations, and international government entities. It has operations in the United States and the United Kingdom. Rigetti Computing, Inc. was founded in 2013 and is headquartered in Berkeley, California.

Receive News & Ratings for Decision Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Decision Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.